Bhorade SM - Search Results

1

Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.

Bhorade SM, Sandesara C, Garrity ER, Vigneswaran WT, Norwick L, Alkan S, Husain AN, McCabe MA, Yeldandi V. Bhorade SM, et al. J Heart Lung Transplant. 2001 Sep;20(9):928-34. doi: 10.1016/s1053-2498(01)00283-2. J Heart Lung Transplant. 2001. PMID: 11557186

2

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients.

Bhorade SM, Lurain NS, Jordan A, Leischner J, Villanueva J, Durazo R, Creech S, Vigneswaran WT, Garrity ER. Bhorade SM, et al. J Heart Lung Transplant. 2002 Dec;21(12):1274-82. doi: 10.1016/s1053-2498(02)00463-1. J Heart Lung Transplant. 2002. PMID: 12490272

3

Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.

Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Bhorade SM, et al. J Heart Lung Transplant. 2008 Sep;27(9):990-4. doi: 10.1016/j.healun.2008.06.005. J Heart Lung Transplant. 2008. PMID: 18765191

4

Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation.

Ghassemieh B, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Garrity ER, Bhorade SM. Ghassemieh B, et al. Among authors: bhorade sm. J Heart Lung Transplant. 2013 Jul;32(7):701-6. doi: 10.1016/j.healun.2013.04.010. Epub 2013 May 7. J Heart Lung Transplant. 2013. PMID: 23664526 Clinical Trial.

5

Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation.

Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Bhorade SM, et al. J Heart Lung Transplant. 2000 Dec;19(12):1199-204. doi: 10.1016/s1053-2498(00)00215-1. J Heart Lung Transplant. 2000. PMID: 11124490

6

Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody.

Garrity ER Jr, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Garrity ER Jr, et al. Among authors: bhorade sm. Transplantation. 2001 Mar 27;71(6):773-7. doi: 10.1097/00007890-200103270-00015. Transplantation. 2001. PMID: 11330541

7

Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.

Bhorade SM, Jordan A, Villanueva J, Yu A, Kramer H, Vigneswaran WT, Garrity ER. Bhorade SM, et al. Am J Transplant. 2003 Dec;3(12):1570-5. doi: 10.1046/j.1600-6135.2003.00260.x. Am J Transplant. 2003. PMID: 14629288 Free article.

8

Immunosuppressive regimens in lung transplant recipients.

Bhorade SM, Villanueva J, Jordan A, Garrity ER. Bhorade SM, et al. Drugs Today (Barc). 2004 Dec;40(12):1003-12. doi: 10.1358/dot.2004.40.12.872575. Drugs Today (Barc). 2004. PMID: 15645011 Review.

9

Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation.

Bhorade SM, Husain AN, Liao C, Li LC, Ahya VN, Baz MA, Valentine VG, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Garrity ER, Arcasoy SM. Bhorade SM, et al. Chest. 2013 Jun;143(6):1717-1724. doi: 10.1378/chest.12-2107. Chest. 2013. PMID: 23370547 Clinical Trial.

10

Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome.

Vigneswaran WT, Bhorade S, Wolfe M, Pelletiere K, Garrity ER Jr. Vigneswaran WT, et al. Int Surg. 2007 Mar-Apr;92(2):93-8. Int Surg. 2007. PMID: 17518251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page